Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction

ASAIO Journal

Volumn 53, Issue 4, 2007, Pages 485-488

  Thomas, Chandra M ^a   Zhang, Jianguo ^a   Lim, Teik How ^a   Scott Douglas, Nairne ^a   Hons, Ronald B ^a   Hemmelgarn, Brenda R ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETERS; GENETIC ENGINEERING; HEMODIALYZERS; PATIENT MONITORING; TISSUE;

CRUDE RATE; HEPARIN CONCENTRATIONS; INTERDIALYTIC LOCKING; MALFUNCTION; PLASMINOGEN ACTIVATOR;

PROTEINS;

ALTEPLASE; HEPARIN;

ADULT; AGED; ARTICLE; CANADA; CATHETER COMPLICATION; CENTRAL VEIN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; FEMALE; HAZARD RATIO; HEMODIALYSIS; HUMAN; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK; TREATMENT DURATION;

AGED; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EQUIPMENT FAILURE; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECOMBINANT PROTEINS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SOLUTIONS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 34547683238     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3180619519     Document Type: Article

References (17)

1. Rayner HC, Pisoni RL, Gillespie BW, et al: Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 63: 323-330, 2003.
2. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL: Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 21: 721-728, 2005.
3. Canadian Organ Replacement Registry Report: Treatment of End-Stage Organ Failure in Canada 2002 and 2003. Canadian Institute for Health Information, Ottawa: 2005.
4. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127: 275-280, 1997.
5. Nassar GM, Ayus JC: Infectious complications of the hemodialysis access. Kidney Int 60: 1-13, 2001.
6. Little MA, Walshe JJ: A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction. Am J Kidney Dis 39: 86-91, 2002.
7. Manns B, Tonelli M, Yilmaz S, et al: Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 16: 201-209, 2005.
8. Beathard GA: Catheter thrombosis. Semin Dial 14: 441-445, 2001.
9. Schwab SJ, Beathard G: The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int 56: 1-17, 1999.
10. Stas KJ, Vanwalleghem J, De Moor B, Keuleers H: Trisodium citrate 30% vs heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis. Nephrol Dial Transplant 16: 1521-1522, 2001.
11. Weijmer MC, van den Dorpel MA, Van de Ven PJ: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16: 2769-2777, 2005.
12. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P: Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 22: 945-947, 1998.
13. Karaaslan H, Peyronnet P, Benevent D, Lagarde C, Rince M, Leroux-Robert C: Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. Nephrol Dial Transplant 16: 2072-2074, 2001.
14. Manns BJ, Mortis GP, Taub KJ, McLaughlin K, Donaldson C, Ghali WA: The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Clin Invest Med 24: 164-170, 2001.
15. Hougaard P: Analysis of Multivariate Survival Data. Springer, New York, 2000.
16. Clayton DG: A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65: 141-151, 1978.
17. Food and Drug Administration, FDA Issues Warning on triCitrasol Dialysis Catheter Anticoagulant, in FDA Talk Paper T00-16. 2000, US Food and Drug Administration: Rockville, MD.